NPR News: FDA's Approval Of A Cheaper Drug For Hepatitis C Will Likely Expand Treatment

FDA's Approval Of A Cheaper Drug For Hepatitis C Will Likely Expand Treatment
Mavyret, recently approved by the Food And Drug Administration, can cure hepatitis C in eight weeks, at a cost of $26,400. Though still expensive, that's well below the price of other options.

Read more on NPR
October 4, 2017 at 04:00PM
Health Care